Glow Lifetech Announces Closing of Non-Brokered Private Placement Offering of Units and Debt Settlement

Counsel to Glow Lifetech Corp. with respect to its completed non-brokered private placement offering of 18,000,000 units for total gross proceeds of $900,000.

Lead by

On November 29, 2024, Glow Lifetech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) (“Glow”) announced that they had completed a non-brokered private placement offering of 18,000,000 units at a price of $0.05 per Unit for total gross proceeds of $900,000.

Glow is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

Miller Thomson advised Glow with a team comprised of Alexander Lalka, Ian Polisuk and Calvin Wang (Corporate/M&A).

Back to top